纳米载体与先进纳米递送技术在药物研发中的应用 | BMRI 征稿

• Nanocarriers for cancer therapy: targeted chemotherapy, immunotherapy, and combination therapy.

• Nanocarriers in gene and nucleic acid delivery (siRNA, miRNA, mRNA, CRISPR systems).

• Nano-enabled drug delivery for neurological disorders and blood–brain barrier targeting.

• Nanocarriers for oral, transdermal, pulmonary, ocular, and vaginal drug delivery.

• Nanoformulations to enhance solubility, bioavailability, and pharmacokinetic performance of poorly soluble drugs.

• Exosomes and biomimetic nanocarriers in advanced therapeutics.

• Nanocarriers in antimicrobial and antiviral drug delivery.

• Stimuli-responsive and smart nanocarriers (pH-, temperature-, enzyme-, redox-, magnetic-, or light-triggered systems).

• Lipid-based nanocarriers (liposomes, solid lipid nanoparticles, nanostructured lipid carriers, lipid nanoparticles) in drug and gene delivery.

• Polymeric nanoparticles, dendrimers, micelles, polymersomes, and nanogels for controlled and sustained release.

• Role of nanocarriers in modulating gut microbiota and microbiome-targeted therapies.

• AI- and machine learning–assisted design and optimization of nanocarriers.

• Predictive modeling of nanocarrier physicochemical properties, stability, and drug release kinetics.

• AI-based optimization of formulation parameters using Quality by Design (QbD) principles.

• Computational modeling and in silico simulation of nano–bio interactions.

• AI-driven prediction of nanotoxicity, biodistribution, and pharmacokinetics.

📌 本期特刊截稿日期：

Monday, 31 August 2026

📤  欢迎分享给你的研究群组、学生、合作伙伴～

期刊简介

扫码填写表单，申请担任 Wiley 的客座编辑

https://uao.so/pct567c0d0

 如您符合要求，Wiley内容战略发展团队将会尽快联系您